Evidence map›Paper›PMID 29126808›Full record

ArticleVaccine2018

Innovative vaccine delivery strategies in response to a cholera outbreak in the challenging context of Lake Chilwa. A rapid qualitative assessment.

Leonard W Heyerdahl, Bagrey Ngwira, Rachel Demolis, Gabriel Nyirenda, Maurice Mwesawina, Florentina Rafael, Philippe Cavailler, Jean Bernard Le Gargasson, Martin A Mengel, Bradford D Gessner and 1 more

Abstract read
In one paragraph

Article in Vaccine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Comprehensive Review on the Use of Oral Cholera Vaccine (OCV) in Ethiopia: 2019 to 2023.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Oral cholera vaccine in cholera prevention and control, Malawi.Bulletin of the World Health Organization · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Leonard W HeyerdahlAgence de Médecine Préventive, Abidjan, Cote d'Ivoire. Electronic address: lheyerdahl@aamp.org.
Bagrey NgwiraUniversity of Malawi, College of Medicine, Community Health Department, Blantyre, Malawi.
Rachel DemolisAgence de Médecine Préventive, Ferney-Voltaire, France.
Gabriel NyirendaUniversity of Malawi, College of Medicine, Community Health Department, Blantyre, Malawi.
Maurice MwesawinaMinistry of Health Malawi, Lilongwe, Malawi.
Florentina RafaelAgence de Médecine Préventive, Abidjan, Cote d'Ivoire.
Philippe CavaillerAgence de Médecine Préventive, Ferney-Voltaire, France.
Jean Bernard Le GargassonAgence de Médecine Préventive, Ferney-Voltaire, France.
Martin A MengelAgence de Médecine Préventive, Paris, France.
Bradford D GessnerAgence de Médecine Préventive, Paris, France.
Elise GuillermetAgence de Médecine Préventive, Ferney-Voltaire, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A reactive campaign using two doses of Shanchol Oral Cholera Vaccine (OCV) was implemented in 2016 in the Lake Chilwa Region (Malawi) targeting fish dependent communities. Three strategies for the second vaccine dose delivery (including delivery by a community leader and self-administration) were used to facilitate vaccine access. This assessment collected vaccine perceptions and opinions about the OCV campaign of 313 study participants, including: fishermen, fish traders, farmers, community leaders, and one health and one NGO officer. Socio-demographic surveys were conducted, In Depth Interviews and Focus Group Discussions were conducted before and during the campaign. Some fishermen perceived the traditional delivery strategy as reliable but less practical. Delivery by traditional leaders was acceptable for some participants while others worried about traditional leaders not being trained to deliver vaccines or beneficiaries taking doses on their own. A slight majority of beneficiaries considered the self-administration strategy practical while some beneficiaries worried about storing vials outside of the cold chain or losing vials. During the campaign, a majority of participants preferred receiving oral vaccines instead of injections given ease of intake and lack of pain. OCV was perceived as efficacious and safe. However, a lack of information on how sero-protection may be delayed and the degree of sero-protection led to loss of trust in vaccine potency among some participants who witnessed cholera cases among vaccinated individuals. OCV campaign implementation requires accompanying communication on protective levels, less than 100% vaccine efficacy, delays in onset of sero-protection, and out of cold chain storage.

Indexed as

Administration, OralAttitude to HealthCholeraCholera VaccinesDisease OutbreaksFemaleFocus GroupsHumansLakesMalawiMaleMass VaccinationRefrigerationSelf AdministrationSurveys and QuestionnairesVulnerable PopulationsCholera VaccinesAnthropologyAttitude to healthCholera vaccinesFishermenSelf administrationVulnerable population

Identifiers

PMID29126808
PMCPMC6189868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.